Tretinoin Global Market 2019 Top Key Players – BASF, LGM Pharma, GF Health,  Gyma Laboratories, Genemed Synthesis  and Forecast to 2023

Global Tretinoin Market

WiseGuyRerports.com Presents “Global Tretinoin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” New Document to its Studies Database. The Report Contain 136 Pages With Detailed Analysis.

Description

Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to treat acne vulgaris. It is also used orally to treat acute promyelocytic leukemia (APL). Its isomer, isotretinoin, is also an acne drug. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.

Scope of the Report: 
This report focuses on the Tretinoin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. 

Market Segment by Manufacturers, this report covers BASF, LGM Pharma, GF Health, Gyma Laboratories, Genemed Synthesis, IMCoPharma, Chongqing Huabang, Olon S.p.A., Sun Pharma. 

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/3370875-global-tretinoin-market-2018-by-manufacturers-regions-type

The worldwide market for Tretinoin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers 
BASF 
LGM Pharma 
GF Health 
Gyma Laboratories 
Genemed Synthesis 
IMCoPharma 
Chongqing Huabang 
Olon S.p.A. 
Sun Pharma.

Market Segment by Regions, regional analysis covers 
North America (United States, Canada and Mexico) 
Europe (Germany, France, UK, Russia and Italy) 
Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
South America (Brazil, Argentina, Colombia etc.) 
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers 
0.1% Tretinoin 
0.02% Tretinoin 
0.025% Tretinoin 
0.05% Tretinoin

Market Segment by Applications, can be divided into 
Skin Use 
Leukemia

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3370875-global-tretinoin-market-2018-by-manufacturers-regions-type

 

Table of Contents -Major Key Points

1 Market Overview 
1.1 Tretinoin Introduction 
1.2 Market Analysis by Type 
1.2.1 0.1% Tretinoin 
1.2.2 0.02% Tretinoin 
1.2.3 0.025% Tretinoin 
1.2.4 0.05% Tretinoin 
1.3 Market Analysis by Applications 
1.3.1 Skin Use 
1.3.2 Leukemia 
1.4 Market Analysis by Regions 
1.4.1 North America (United States, Canada and Mexico) 
1.4.1.1 United States Market States and Outlook (2013-2023) 
1.4.1.2 Canada Market States and Outlook (2013-2023) 
1.4.1.3 Mexico Market States and Outlook (2013-2023) 
1.4.2 Europe (Germany, France, UK, Russia and Italy) 
1.4.2.1 Germany Market States and Outlook (2013-2023) 
1.4.2.2 France Market States and Outlook (2013-2023) 
1.4.2.3 UK Market States and Outlook (2013-2023) 
1.4.2.4 Russia Market States and Outlook (2013-2023) 
1.4.2.5 Italy Market States and Outlook (2013-2023) 
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
1.4.3.1 China Market States and Outlook (2013-2023) 
1.4.3.2 Japan Market States and Outlook (2013-2023) 
1.4.3.3 Korea Market States and Outlook (2013-2023) 
1.4.3.4 India Market States and Outlook (2013-2023) 
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 
1.4.4 South America, Middle East and Africa 
1.4.4.1 Brazil Market States and Outlook (2013-2023) 
1.4.4.2 Egypt Market States and Outlook (2013-2023) 
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 
1.4.4.4 South Africa Market States and Outlook (2013-2023) 
1.4.4.5 Nigeria Market States and Outlook (2013-2023) 
1.5 Market Dynamics 
1.5.1 Market Opportunities 
1.5.2 Market Risk 
1.5.3 Market Driving Force 

2 Manufacturers Profiles 
2.1 BASF 
2.1.1 Business Overview 
2.1.2 Tretinoin Type and Applications 
2.1.2.1 Product A 
2.1.2.2 Product B 
2.1.3 BASF Tretinoin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.2 LGM Pharma 
2.2.1 Business Overview 
2.2.2 Tretinoin Type and Applications 
2.2.2.1 Product A 
2.2.2.2 Product B 
2.2.3 LGM Pharma Tretinoin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.3 GF Health 
2.3.1 Business Overview 
2.3.2 Tretinoin Type and Applications 
2.3.2.1 Product A 
2.3.2.2 Product B 
2.3.3 GF Health Tretinoin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.4 Gyma Laboratories 
2.4.1 Business Overview 
2.4.2 Tretinoin Type and Applications 
2.4.2.1 Product A 
2.4.2.2 Product B 
2.4.3 Gyma Laboratories Tretinoin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.5 Genemed Synthesis 
2.5.1 Business Overview 
2.5.2 Tretinoin Type and Applications 
2.5.2.1 Product A 
2.5.2.2 Product B 
2.5.3 Genemed Synthesis Tretinoin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.6 IMCoPharma 
2.6.1 Business Overview 
2.6.2 Tretinoin Type and Applications 
2.6.2.1 Product A 
2.6.2.2 Product B 
2.6.3 IMCoPharma Tretinoin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 

……..CONTINUED
  

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)      

This release was published on openPR.